GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Hyper Corporation Inc (XKRX:065650) » Definitions » Price-to-Funds-From-Operations

Hyper (XKRX:065650) Price-to-Funds-From-Operations : (As of May. 26, 2024)


View and export this data going back to 2003. Start your Free Trial

What is Hyper Price-to-Funds-From-Operations?

Price-to-Funds-From-Operations only applies to REITs.


Hyper (XKRX:065650) Business Description

Traded in Other Exchanges
N/A
Address
Woolim A-1401, 583, Yangcheon-ro, Gangseo-gu, Seoul, KOR, 07547
Medifron DBT Co Ltd is a Korean clinical stage biopharmaceutical company. The company is focused on the development of Alzheimer's disease (AD) and neuropathic pain (NP) treatment and AD diagnostics.